Total Payments
$129,890
2024 Payments
$10,244
Companies
25
Transactions
624
Medicare Patients
2,844
Medicare Billing
$566,678
Payment Breakdown by Category
Other$100,426 (77.3%)
Food & Beverage$10,867 (8.4%)
Travel$9,549 (7.4%)
Consulting$9,000 (6.9%)
Education$47.77 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $100,426 | 41 | 77.3% |
| Food and Beverage | $10,867 | 547 | 8.4% |
| Travel and Lodging | $9,549 | 28 | 7.4% |
| Consulting Fee | $9,000 | 4 | 6.9% |
| Education | $47.77 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $119,159 | 302 | $0 (2024) |
| ABBVIE INC. | $7,481 | 118 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $879.37 | 57 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $528.00 | 43 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $268.30 | 12 | $0 (2023) |
| Allergan Inc. | $221.45 | 17 | $0 (2019) |
| Braintree Laboratories, Inc. | $195.30 | 10 | $0 (2023) |
| RedHill Biopharma Inc. | $148.43 | 8 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $137.16 | 8 | $0 (2018) |
| Madrigal Pharmaceuticals | $103.96 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,244 | 32 | Gilead Sciences, Inc. ($9,860) |
| 2023 | $10,069 | 42 | Gilead Sciences, Inc. ($9,496) |
| 2022 | $7,417 | 61 | Gilead Sciences, Inc. ($6,716) |
| 2021 | $23,112 | 119 | Gilead Sciences, Inc. ($22,224) |
| 2020 | $21,019 | 79 | Gilead Sciences, Inc. ($20,359) |
| 2019 | $44,268 | 111 | Gilead Sciences, Inc. ($42,325) |
| 2018 | $12,547 | 105 | Gilead Sciences, Inc. ($7,880) |
| 2017 | $1,214 | 75 | AbbVie, Inc. ($352.64) |
All Payment Transactions
624 individual payment records from CMS Open Payments — Page 3 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: VIROLOGY | ||||||
| 05/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.82 | General |
| 05/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.18 | General |
| 05/01/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $82.62 | General |
| Category: VIROLOGY | ||||||
| 05/01/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: VIROLOGY | ||||||
| 04/27/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $27.33 | General |
| Category: GI | ||||||
| 04/26/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Gastroenterology | ||||||
| 04/22/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: VIROLOGY | ||||||
| 04/19/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $115.74 | General |
| Category: HBV | ||||||
| 04/13/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: VIROLOGY | ||||||
| 04/12/2023 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: GI COLON PREP | ||||||
| 04/10/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Immunology | ||||||
| 04/04/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 03/29/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: VIROLOGY | ||||||
| 03/16/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.14 | General |
| 03/14/2023 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/02/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Immunology | ||||||
| 03/02/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: VIROLOGY | ||||||
| 02/25/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: HCV | ||||||
| 02/22/2023 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Gastroenterology | ||||||
| 02/03/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.58 | General |
| 01/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.14 | General |
| 01/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $8.87 | General |
| 11/11/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 633 | 979 | $316,660 | $107,065 |
| 2022 | 7 | 652 | 971 | $377,025 | $123,953 |
| 2021 | 6 | 844 | 1,275 | $489,435 | $184,933 |
| 2020 | 6 | 715 | 1,083 | $414,724 | $150,728 |
Total Patients
2,844
Total Services
4,308
Medicare Billing
$566,678
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 376 | $94,000 | $33,807 | 36.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 66 | 66 | $85,800 | $27,511 | 32.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 173 | 330 | $57,750 | $20,156 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 98 | 98 | $28,910 | $12,431 | 43.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 26 | 27 | $29,700 | $10,096 | 34.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 56 | 82 | $20,500 | $3,064 | 14.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 88 | 88 | $114,400 | $38,312 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 181 | 321 | $80,250 | $31,572 | 39.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 175 | 339 | $84,750 | $17,886 | 21.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 43 | 44 | $48,400 | $17,353 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 122 | 122 | $36,100 | $14,897 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 39 | $6,825 | $2,783 | 40.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 18 | 18 | $6,300 | $1,151 | 18.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 128 | 128 | $166,400 | $54,861 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 229 | 497 | $124,250 | $52,173 | 42.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 178 | 178 | $52,510 | $24,868 | 47.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 56 | 57 | $62,700 | $21,997 | 35.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 146 | 269 | $47,075 | $21,105 | 44.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 107 | 146 | $36,500 | $9,930 | 27.2% |
| 45380 | Biopsy of large bowel using an endoscope | Office | 2020 | 110 | 111 | $144,300 | $46,109 | 32.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 206 | 419 | $104,750 | $38,155 | 36.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 175 | 328 | $57,400 | $22,777 | 39.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 162 | 162 | $47,790 | $22,073 | 46.2% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 51 | 52 | $57,200 | $19,758 | 34.5% |
| 45330 | Diagnostic examination of large bowel using an endoscope | Office | 2020 | 11 | 11 | $3,284 | $1,855 | 56.5% |
About Dr. Ralph Peterson, MD
Dr. Ralph Peterson, MD is a Gastroenterology healthcare provider based in Oakland, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851311104.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Peterson, MD has received a total of $129,890 in payments from pharmaceutical and medical device companies, with $10,244 received in 2024. These payments were reported across 624 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($100,426).
As a Medicare-enrolled provider, Peterson has provided services to 2,844 Medicare beneficiaries, totaling 4,308 services with total Medicare billing of $566,678. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Oakland, CA
- Active Since 07/20/2006
- Last Updated 12/02/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851311104
Products in Payments
- Epclusa (Drug) $87,198
- Vemlidy (Drug) $3,990
- XIFAXAN (Drug) $791.97
- Mavyret (Drug) $559.50
- MAVYRET (Drug) $477.23
- MOTEGRITY (Drug) $339.08
- CREON (Drug) $329.20
- LINZESS (Drug) $325.49
- ZENPEP (Drug) $289.15
- Creon (Drug) $270.96
- VIBERZI (Drug) $182.44
- SUTAB (Drug) $167.36
- ZEPATIER (Drug) $137.16
- TRULANCE (Drug) $128.82
- Viekira (Drug) $124.30
- Amitiza (Drug) $119.75
- RESMETIROM (Drug) $103.96
- Talicia (Drug) $91.59
- Donnatal (Drug) $79.43
- IBSRELA (Drug) $72.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Oakland
Dr. Neil Stollman, Md, MD
Gastroenterology — Payments: $171,798
Gastroenterology $171,798
Ms. Susie Cohn, Md, MD
Gastroenterology — Payments: $13,313
Gastroenterology $13,313
Dr. Liana Vesga, Md, MD
Gastroenterology — Payments: $12,795
Gastroenterology $12,795
Dr. Silvia Villagomez, Md, MD
Gastroenterology — Payments: $11,402
Gastroenterology $11,402
Dr. Earl Darby, Md, MD
Gastroenterology — Payments: $5,922
Gastroenterology $5,922
Dr. Paul Chard, Md Phd, MD PHD
Gastroenterology — Payments: $4,744
Gastroenterology $4,744